Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
The aim of our research was to determine the use of CA125 and HE4 as prognostic factors in patients with different clinical staging of endometrial cancer. Sixty-two patients with advanced endometrial cancer and 287 patients with early stage endometrial cancer participated in the study. Based on the...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2021-03-01
|
| Saila: | Diagnostics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2075-4418/11/4/626 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|